CASR and nephrolithiasis: CLDN14 is expressed in collecting ducts and acts as a cation barrier. CLDN14 expression is strongly increased by CaSR activation and dysregulation of the renal CaSR-CLDN14 pathway may contribute significantly to kidney stone development [24].